… follicular carcinomas, the second most common type of thyroid … the development of medullary
thyroid carcinomas. Many of … actively explored as therapeutic targets for thyroid cancer. A …

… In papillary thyroid carcinomas, this mutation is associated with … BRAF as a potential therapeutic
target for thyroid carcinoma. … be an appealing therapeutic target for thyroid carcinomas, …

Published guidelines on the treatment of thyroid carcinoma support TSH suppressive
therapy as the standard of care for long-term follow-up after initial surgery and sequential …

… At present, the molecular pathogenesis of thyroid carcinoma … therapies target mature
cancer cells and thus, thyroid CSCs, … therapeutic approaches that target thyroid CSCs (76–78). …

… carcinoma (MTC). The follicular-derived TCs include several histological forms: papillary
thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC… novel potential therapeutic targets for …

… study was to identify potential therapeutic targets for papillary thyroid carcinoma (PTC) and
… of normal thyroid tissues and 7 specimens of well‑differentiated thyroid carcinomas, were …

… provided a list of possible molecular targets for biological therapy in thyroid carcinomas. …
a strong rationale for the use of targeted therapy for all histotypes of thyroid carcinomas. …

… chemotherapy (7), highlighting EGFR as a therapeutic target for any malignancies harboring
such mutations. All thyroid carcinoma cell lines in our panel were EGFR wild type and, in …

Medullary thyroid carcinoma (MTC) is a rare tumour arising from neural crest-derived 2
parafollicular C cells. Metastatic MTC patients are incurable because the cancer does 3 not …

… , the majority are differentiated thyroid carcinomas (DTC), whose … Medullary thyroid carcinoma
has a worse prognosis, especially in … thyroid carcinomas showing very promising results. …